Paroxetine Controlled Release in the Treatment of Menopausal Hot Flashes: A Randomized Controlled Trial

JAMA

Volumn 289, Issue 21, 2003, Pages 2827-2834

  Stearns, Vered ^a,c   Beebe, Katherine L ^b   Iyengar, Malini ^b   Dube, Eric ^b  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ESTRADIOL; FLUOXETINE; PAROXETINE; PLACEBO; RALOXIFENE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; VENLAFAXINE;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPEPSIA; ESTROGEN THERAPY; EVALUATION; FEMALE; HEADACHE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INSOMNIA; INTERMETHOD COMPARISON; LETHARGY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MULTICENTER STUDY; NAUSEA; NIGHT SWEAT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; SCORING SYSTEM; SEROTONIN RELEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URBAN AREA; AGED; DELAYED RELEASE FORMULATION; DRUG EFFECT; HEALTH SURVEY; MIDDLE AGED; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HEALTH STATUS INDICATORS; HOT FLASHES; HUMANS; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0037976797     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.21.2827     Document Type: Article

References (26)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
2. Kronenberg F. Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol. 1994;29:319-336.
3. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci. 1990;592:52-86.
4. US Census Bureau. Resident Population Estimates of the United States by Age and Sex: April 1, 1990 to July 1, 1999, with Short-Term Projection to November 1, 2000. Washington, DC: US Census Bureau; January 2, 2001. Available at: http://www.census .gov/population/estimates/nation/intfile2-1.txt, 2001. Accessed April 22, 2003.
5. Fisher B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst. 1996; 88:1529-1542.
6. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-1388.
7. Fallowfield L, Fleissig A, Edwards R, et al. Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol. 2001;19:1885-1892.
8. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med. 1994;331:347-352.
9. North American Menopausal Society. Amended report from the NAMS advisory panel on postmenopausal hormone therapy. Available at: http://www .menopause.org/news.html_advisory. Accessed November 2002.
10. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002;20:1578-1583.
11. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356:2059-2063.
12. Steams V, Isaacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol. 2000;11:17-22.
13. Stearns V, Ullmer L, Lopez J, Smith Y, Isaacs C, Hayes DF. Hot flushes. Lancet. 2002;360:1851-1861.
14. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998;16:495-500.
15. Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dube EM. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. J Clin Psychiatry. 2002;63:577-584.
16. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22-33.
17. Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-571.
18. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001;19:4280-4290.
19. Goldberg RM, Loprinzi CL, O'Fallon JR, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol. 1994;12:155-158.
20. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152:463-473.
21. Myers RD. Serotonin and thermoregulation: old and new views. J Physiol (Paris). 1981;77:505-513.
22. Lin MT, Tsay HJ, Su WH, Chueh FY. Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function. Am J Physiol. 1998;274: R1260-R1267.
23. Oerther S. Temperature set-point changes induced by DA D2/3 and 5-HT1A receptor agonists in the rat. Neuroreport. 2000;11:3949-3951.
24. Gudelsky GA, Koenig JI, Meltzer HY. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat: evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology. 1986;25:1307-1313.
25. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry. 1998;44:839-850.
26. Lopez JF, Akil H, Watson SJ. Neural circuits mediating stress. Biol Psychiatry. 1999;46:1461-1471.